We at VericiDx are excited to be attending the American Transplant Congress in San Diego hosted by the American Society of Transplantation and the American Society of Transplant Surgeons June 3rd to June 7th. We look forward to sharing our latest results on our post-transplant acute rejection test, Tutivia, as well as meeting with others alike to share collaboration ideas at ATC_Booth1036.
Verici Dx attended and exhibited at the ASN kidney week annual conference, from November 3rd to November 6th, 2022, at the Orlando Convention Center, in Orlando FL.
Verici Dx, Renalytix, AST, and ASN, have partnered to create the Dr. Barbara T. Murphy endowed lectureship starting at ASN Kidney Week 2022. This lectureship commemorates Dr. Murphy and her legacy in transplant immunology, by recognizing advances in kidney transplantation. We were honored to have the first lecture be presented by Rosyln B Mannon, Md, FASN, entitled; Improving kidney graft Long-Term Outcomes: Lessons Learned and New Perspectives.
Dr. Oriol Bestard did an oral presentation; “Clinical performance validation of Tutivia Biomarker” at the ASN kidney week national conference, during the session titled: Transplantation: Clinical Outcomes and Biomarkers.